UCHealth Frontline Staff Leverages Wearable for Post-Vaccine Monitoring

Dec. 21, 2020
UCHealth’s staff and providers will wear the BioButton device for two days prior and seven days following a COVID-19 vaccine dose to detect potential adverse vital sign trends

Some frontline healthcare workers at the Aurora, Colo.-based University of Colorado Hospital (UCHealth) will be using wearable devices to track their health after receiving the COVID-19 vaccine.

As the 12-hospital UCHealth began administering the Pfizer COVID-19 vaccine to healthcare workers late last week at the University of Colorado Hospital on the University of Colorado Anschutz Medical Campus, some recipients will be wearing the BioIntelliSense BioButton medical device, which health system leaders see “as a foundational step in developing a scalable post-vaccine monitoring program that could be deployed more broadly in high-risk patient populations.”

The BioButton medical grade device and data services are offered by BioIntelliSense, a continuous health monitoring and clinical intelligence company based in Golden, Colo. The coin-sized wearable device aims to delivers continuous vital sign monitoring of temperature, respiratory rate and heart rate at rest. According to the manufacturer’s website, the device is indeed an FDA-cleared medical-grade wearable and is designed to be discreetly worn on the upper left chest “for effortless remote data capture and a simplistic ‘stick it on and forget it’ patient experience.”

UCHealth’s staff and providers will wear the BioButton device for two days prior and seven days following a COVID-19 vaccine dose to detect potential adverse vital sign trends. Together with a daily vaccination health survey and data insights, the wearer may be alerted of signs and symptoms to guide appropriate follow-up actions and further medical management, the health system’s officials explained.

“The participation of our frontline healthcare workers in this vaccine monitoring program serves as an important operational milestone in scaling the program for the larger population, particularly with vulnerable patient populations and seniors in long-term care environments,” said Richard Zane, M.D., UCHealth chief innovation officer and professor and chair of emergency medicine at the University of Colorado School of Medicine. “We work closely with partners like BioIntelliSense to not only navigate the ever-changing landscape of healthcare but collaboratively develop the innovative tools that are transforming the way patients receive care.”

James Mault, M.D., CEO of BioIntelliSense, added that his company is “proud to partner with UCHealth in providing our BioIntelliSense medical-grade wearable technology and advanced data services to address high-risk patient populations and to offer peace of mind monitoring for those who may be concerned about receiving the vaccine.”

Sponsored Recommendations

Trailblazing Technologies: Looking at the Top Technologies for the Emerging U.S. Healthcare System

Register for the first session of the Healthcare Innovation Spotlight Series today to learn more about 'Healthcare's New Promise: Generative AI', the latest technology that is...

Data: The Bedrock of Digital Engagement

Join us on March 21st to discover how data serves as the cornerstone of digital engagement in healthcare. Learn from Frederick Health's transformative journey and gain practical...

Northeast Georgia Health System: Scaling Digital Transformation in a Competitive Market

Find out how Northeast Georgia Health System (NGHS) enabled digital access to achieve new patient acquisition goals in Georgia's highly competitive healthcare market.

2023 Care Access Benchmark Report for Healthcare Organizations

To manage growing consumer expectations and shrinking staff resources, forward-thinking healthcare organizations have adopted digital strategies, but recent research shows that...